17/12/2007 (Agence Europe) - The European Medicines Agency has asked the Pfizer laboratory to make changes to information provided about Champix (varenicline), to warn patients and doctors of the risks of depression and suicidal behaviour associated with the use of this product, which is used to help people stop smoking. (O.J.)